DMTs Underutilized in Younger Patients, Study Indicates

DMTs Underutilized in Younger Patients, Study Indicates

296346

DMTs Underutilized in Younger Patients, Study Indicates

Nearly a third of people with multiple sclerosis (MS) who are younger than 40 are not being treated with disease-modifying treatments (DMTs), even though younger individuals are expected to get the most benefit from DMTs, according to a new study. “DMTs for MS are more frequently used at younger ages when there is likely higher disease activity, yet a substantial proportion of younger PwMS [people with MS] remains untreated,” researchers wrote. The study also suggested…

You must be logged in to read/download the full post.